DoW, Peer Reviewed Cancer, Impact Award
Funds mature cancer research with near-term clinical potential; trials are allowed but not required, unlike its Clinical Trial Award sibling.
Between an idea that is still basic research and a full clinical trial sits a stage that is often the hardest to fund: work far enough along to matter soon, but not yet ready to be called a trial.
The Impact Award is built for that stage. It funds mature research with strong potential for near-term impact on clinical cancer care, inside one of the programme's congressionally directed FY26 Topic A…
Mature research with strong potential for near-term impact on clinical cancer care, within a congressionally directed FY26 PRCRP Topic Area, advancing knowledge, patient care or treatment options in the Military Health System. Preliminary data supporting feasibility is required. Clinical trials are permitted but not required. Supports a single Principal Investigator or two partnering PIs, with only the Initiating PI submitting a pre-application.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up